Publication:
Approaches of pediatric nephrologists to hypertensive patients in Turkey (Turkish pediatric hypertension working group study)

dc.contributor.coauthorDemir, Belde Kasap
dc.contributor.coauthorHacıhamdioğlu, Duygu Övüç
dc.contributor.coauthorGirişgen, İlknur
dc.contributor.coauthorDursun, Hasan
dc.contributor.coauthorÇivilibal, Mahmut
dc.contributor.coauthorBenzer, Meryem
dc.contributor.coauthorBıyıklı, Neşe Karaaslan
dc.contributor.coauthorÖzkayın, Neşe
dc.contributor.coauthorSönmez, Ferah
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorTaşdemir, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-10T00:07:31Z
dc.date.issued2018
dc.description.abstractObjective: We aimed to evaluate the approaches of pediatric nephrologists in our country to the management of childhood hypertension. Methods: The pediatric nephrologists in our country were invited to fill out an online questionnaire including 24 questions. The answers were compared between those working in the field for <= 10 years (Group 1, n =74) and >10 years (Group 2, n = 62). Results: of 136 participants (M/F = 101/35), 52% were following a single guideline [31% Fourth Report of 2004, 17% European Society of Hypertension in 2016, and 52% American Academy of Pediatrics in 2017], which is more common in Group 1 (P =.035). The most commonly used guideline was American Academy of Pediatrics of 2017 and Group 2 used Fourth Report of 2004 more commonly (P =.042). The most common choice to diagnose hypertension was office + home + ambulatory blood pressure monitoring (59%). The frequency of screening for end-organ damage at first evaluation was 96%. The time to wait for the effect of lifestyle modifications was 3 months in 52%. The first choice medication was angiotensin-converting enzyme inhibitors (49%) or calcium-channel blockers (48%) in non-obese and angiotensin-converting enzyme inhibitors (74%) in obese children. Calcium-channel blockers were more commonly prescribed as the first choice in non-obese children in Group 1 (P =.035). The most accessible emergency drug was esmolol. Conclusion: Despite following recent guidelines, the time spent in the proficiency would change the practices.
dc.description.indexedbyWOS
dc.description.indexedbyTR Dizin
dc.description.issue10
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume33
dc.identifier.eissn1432-198X
dc.identifier.issn0931-041X
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85130068348
dc.identifier.urihttps://link.springer.com/article/10.1007/s00467-018-4028-x
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16786
dc.identifier.wos834658600004
dc.keywordsHypertension
dc.keywordsChildren
dc.keywordsAdolescents
dc.keywordsGuidelines
dc.keywordsClinical practice patterns
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofPediatric Nephrology
dc.subjectPediatrics
dc.subjectUrology
dc.subjectNephrology
dc.titleApproaches of pediatric nephrologists to hypertensive patients in Turkey (Turkish pediatric hypertension working group study)
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorTaşdemir, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files